ARCHIVES

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

This article is from The Cancer Letter archive.

Vol. 03 No. 40 | October 7, 1977

Download PDF Visit The Full Archive

Related Articles

Harold Varmus Plans To Leave Presidency Of MSKCC

January 15, 2010

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000

Fisher Says Forget Grants-Contract Argument; What’s Needed Is More Flexibility

April 13, 1979

Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock.

March 11, 2005

Stereotactic Radiosurgery Improves Survival Without Whole-Brain Radiotherapy

September 27, 2013

Congressional Committees Add Provisions To Cancer Act Renewal Bills To Strengthen NCI’s Independence, Prevent Fund Withholding

March 8, 1974